The present disclosure generally relates to sponges (e.g., gauze) suitable for use in medical procedures, which may include radio-opaque markers and optionally wireless transponders.
Sponges of a variety of forms have long been a staple article used in performing medical procedures, for instance surgeries, labor and deliver (L&D), emergency room (ER) procedures, and even general clinical procedures. Medical care providers (e.g., physicians, nurses, dentists, orderlies) typically use sponges to soak up blood and other bodily fluids, to apply pressure, or to fill cavities in bodily organs or structures.
Sponges typically comprise gauze, folded into several layers. Sponges often resemble multi-layer rectangular pads, although other may come in other shapes. The gauze is typically sterile prior to use, and may or may not be received in sterile packaging. Sponges typically employ a lint free material, to prevent leaving stray portions behind during a medical procedure.
Unintentional foreign body retention is a concern during many medical procedures, particularly during surgical or L&D procedures. Medical care providers may employ sponges in various cavities in the body during the procedure. The sponges can be difficult to visually locate in the body, particularly after absorbing fluids such as blood. If left in the body, a sponge may be a source of infection or may give rise to other complications. Such can cause adverse heath consequence, requiring further medical procedures, and even lead to long term illness or even death.
In an effort to prevent unintentional retention of sponges, some hospitals have instituted procedures which include checklists or require multiple counts to be performed to track the use and return of objects during surgery. Such manual approaches are inefficient, requiring the time of highly trained personnel, and are prone to error.
In an effort to further prevent unintentional retention of sponges, many sponges are marked or tagged with radio-opaque material. Radio-opaque material tends to absorb electromagnetic energy in the X-ray or even Gamma ray ranges of frequencies, causing such material to be visually apparent via X-ray medical imaging.
As a further effort to prevent unintentional retention of sponges, some sponges are marked or tagged with wireless transponders. These wireless transponders are typically of one of two types: i) LC resonant transponder, or ii) radio-frequency identification (RFID) transponders.
LC resonant transponders are typically very simple circuits, comprising an inductor and a capacitor which resonate at some defined frequencies, hence the name LC resonant transponder. The LC resonant transponder returns a wireless response signal at or proximate a defined frequency in response to being subjected to wireless interrogation signal at or proximate a defined frequency (e.g., pulsed wideband wireless signals). Depending on the LC resonant transponder, the wireless response signal may be at the same or at a different frequency than the interrogation signal. The LC resonant transponder does not store or provide any unique identification information or identifier. Thus, the LC resonant transponder serves as a simple presence/absence transponder, similar in some respects to Electronic Article Surveillance (EAS) transponders or tags commonly encounters on retail goods in retail stores.
RFID transponders typically take the form of a passive RFID transponder, that is one that derives power from an interrogation signal rather than from an on-board battery. RFID transponders are typically more complicated than LC resonant transponders. For example, passive RFID transponders have power circuitry which converts an RF or microwave signal into DC power, and a storage device (e.g., capacitor) for temporarily storing power to power the passive RFID transponder when being interrogated. RFID transponders typically have one or more memories, at least one of which stores a unique identifier. The unique identifier is encoded in a response signal which the RFID transponder returns in response to an interrogation signal. Some RFID transponders have memory that cannot only be read, but can also be written to more than once. Some RFID transponders have logic circuits, and may recognize commands, and even be able to recognize commands that are addressed to the specific RFID transponder. While denominated as “radio frequency identification” RFID transponders typically operate in either the radio or the microwave frequency bands of the electromagnetic spectrum.
LC transponders have been successfully used to determine the presence or absence of sponges in the body during medical procedures. Examples of such an approach are discussed in U.S. Pat. No. 6,026,818, issued Feb. 22, 2000, and U.S. Patent Publication No. US 2004/0250819, published Dec. 16, 2004.
In contrast, RFID transponders are typically used in a count-in/count-out process during medical procedures. The count-in/count-out process typically requires taking an inventory of all RFID transponder tagged objects before or at the start of a medical procedure, then taking an inventory of all RFID transponder tagged objects after or at the end of the medical procedure, and comparing the inventories.
Producing sponges typically employs many automated operations and/or manual operations. Strips of gauze may be cut into defined lengths, and folded into sponges. The gauze may include one or more radio-opaque makers. The radio-opaque markers may be woven into the gauze, for instance during the manufacturing of the gauze itself, or following manufacturing of the gauze. Alternatively, or additionally, radio-opaque markers may be applied, fixed or otherwise attached the gauze after manufacture of the gauze.
The gauze may additionally, or alternatively, include one or more wireless transponders. The wireless transponders may take any of a variety of forms, for example LC resonant transponders or RFID transponders, or both. Notably, LC resonant transponders may operate at relatively lower frequencies as compared to the frequencies typical of passive RFID transponders. This provides greater range when the transponder is in bodily tissue, enhancing detectability in the body. The wireless transponders may be applied, fixed or otherwise attached to the gauze, typically before being folding.
The wireless transponder(s) may, for example, be encased in a closed pouch, before being attached to the gauze, for example via sewing or stitching, or via heat sealing or welding for instance RF heat welding. In some implementations, the pouch may take the form of laminate, for instance a pouch of thermoplastic polyurethane (TPU), nylon and/or or polyvinyl chloride (PVC) impregnated fabric.
Alternatively, the wireless transponder(s) may, for example, be encased between the piece of gauze and another piece of material, The other piece of material may take the form of a textile, for example a woven or knitted textile. Alternatively, the other piece of material may take the form of a membrane, for example a polymer membrane, for instance a membrane of thermoplastic polyurethane (TPU), nylon or polyvinyl chloride (PVC) impregnated fabric. In some implementations, the other piece of material may take the form of laminate. The other piece of material may be attached to the gauze, for example via sewing or stitching, or via heat sealing or welding for instance RF heat welding, trapping the wireless transponder between the piece of gauze and the other piece of material.
As a further alternative, the wires transponder may be directly applied, fixed or otherwise attached to the gauze, for example via a bio-compatible adhesive, bio-compatible epoxy or encapsulant, or via heat sealing or RF welding.
Sets of sponges may be packaged together in packets. For example, a set of five sponges may be packaged together. An imaging system may image the set of sponges to assure that each set, packet or package contains a set number of sponges. For example, an X-ray imaging system may irradiate a set of sponges. The X-ray imaging system may irradiate the sponges from the side, rather than face on, to detect the presence of the radio-opaque material (e.g., radio-opaque threads) carried by each sponge. Sponge configuration, and in particular the location of the radio-opaque material and/or transponders may substantially enhance the ability to correctly discern and count the total number of sponges in each set, packet or package. For example, various folding techniques configurations described and illustrated described herein optimally space the radio-opaque material of one sponge from the radio-opaque material of adjacent sponges. Also for example, various folding techniques and configurations described and illustrated herein optimally space the transponder with respect to the radio-opaque material.
Sets, packets or packages of sponges may be identified to represent that the count of sponges in each has been verified. For example the set of sponges may be wrapped with a band that bears an authentication symbol (e.g. trademark, logo, hologram, machine-readable symbol and/or wirelessly readable identifier).
A sponge may be summarized as including a piece of gauze folded into at least three panels which overlap with one another, including a first outer panel, a second outer panel and at least a first inner panel located interposed between the first outer panel and the second outer panel; and a first radio-opaque material carried by the first inner panel.
The piece of gauze may be folded into at least four panels which overlap with one another, including in addition to the first outer panel, the second outer panel and the first inner panel at least a second inner panel interposed between the first outer panel and the second outer panel, and may further include a second radio-opaque material carried by the second inner panel. The first radio-opaque material may be a first radio-opaque thread woven into the gauze. The first radio-opaque material may be a first radio-opaque thread attached to a face of the gauze. The first radio-opaque material may be a first radio-opaque thread attached to a face of the first inner panel that faces the first outer panel and the second radio-opaque material may be a second radio-opaque thread attached to a face of the second inner panel that faces the second outer panel. In a pre-folded configuration, the piece of gauze may have a left-most portion and a right-most portion with respect to a centerline that traverses a width of the gauze along a longitudinal length thereof, and in a folded configuration, the left-most portion of the piece of gauze may be immediately adjacent the right-most portion of the piece of gauze with respect to a thickness of the sponge.
The sponge may further include a transponder attached to the gauze.
The sponge may further include a piece of material that retains the transponder to the gauze.
The sponge may further include a closed pouch which encloses the transponder and which is attached to the gauze.
The sponge may further include a closed pouch which encloses the transponder and which is attached to the gauze via a plurality of stitches. The transponder may be an inductive-capacitive (LC) resonant circuit transponder which does not transmit any unique identifying information. The transponder may be a radio frequency identification (RFID) transponder which transmits a piece of unique identifying information in response to a radio frequency or microwave frequency interrogation signal.
A sponge may be summarized as including a piece of gauze which in a pre-folded configuration has a first major face, a second major face opposed across a thickness of the piece of gauze from the first major face, a first end, a second end, the second end opposed across a length of the piece of gauze from the first end, a first edge and a second edge, the second edge opposed across a width of the piece of gauze; a first piece of elongated radio-opaque material, extending at least partially across the width of the piece of gauze; a second piece of elongated radio-opaque material, extending at least partially across the width of the piece of gauze, the second piece of elongated radio-opaque material spaced along the length of the piece of gauze from the first piece of elongated radio-opaque material in the pre-folded configuration, the piece of gauze folded into a folded configuration with at least three fold lines to form at least four portions, the first and the second pieces of elongated radio-opaque material positioned inwardly of a pair of outermost ones of the at least four portions of the sponge with respect to a thickness of the sponge in the folded configuration; and a transponder attached to the piece of gauze. In the pre-folded configuration, the first piece of elongated radio-opaque material may be located on a first half of the piece of gauze relative to a centerline along the length of the piece of gauze and the second piece of elongated radio-opaque material may be located on the first half of the piece of gauze relative to the centerline. The first piece of elongated radio-opaque material may be a first radio-opaque thread woven into the piece of gauze and the second piece of elongated radio-opaque material may be a second radio-opaque thread woven into the piece of gauze. The first piece of elongated radio-opaque material may be a first radio-opaque thread attached to the first major face of the piece of gauze. The second piece of elongated radio-opaque material may be a second radio-opaque thread attached to the first major face of the piece of gauze. The transponder may be attached to the second major face of the piece of gauze. The first piece of elongated radio-opaque material may be a first radio-opaque thread carried by a first inner portion of the sponge in the folded configuration and the second piece of elongated radio-opaque material may be a second radio-opaque thread carried by a second inner portion of the sponge in the folded configuration, the first and the second inner portions of the sponge interposed between a first and a second outer portions of the sponge in the folded configuration. The piece of gauze may be a continuous piece of gauze, in the pre-folded configuration the piece of gauze may have a left-most portion and a right-most portion with respect to a centerline that traverses the width of the gauze along the length thereof, and in the folded configuration, the left-most portion of the piece of gauze may be immediately adjacent the right-most portion of the piece of gauze with respect to the thickness of the sponge.
The sponge may further include a piece of material that retains the transponder to the piece of gauze.
The sponge may further include a closed pouch which encloses the transponder before the transponder is attached to the piece of gauze and which is attached to the gauze.
The sponge may further include a closed pouch which encloses the transponder and which is attached to the gauze via a plurality of stitches. The transponder may be an inductive-capacitive (LC) resonant circuit transponder which does not transmit any unique identifying information. The transponder may be a radio frequency identification (RFID) transponder which may transmit a piece of unique identifying information in response to a radio frequency or microwave frequency interrogation signal.
A method of producing sponges may be summarized as including providing a piece of gauze in a pre-folded configuration, which has a first major face, a second major face opposed across a thickness of the piece of gauze from the first major face, a first end, a second end, the second end opposed across a length of the piece of gauze from the first end, a first edge and a second edge, the second edge opposed across a width of the piece of gauze, a first piece of elongated radio-opaque material, extending at least partially across the width of the piece of gauze, a second piece of elongated radio-opaque material, extending at least partially across the width of the piece of gauze, the second piece of elongated radio-opaque material spaced along the length of the piece of gauze from the first piece of elongated radio-opaque material in the pre-folded configuration, and a transponder attached to the piece of gauze; and folding the piece of gauze into a folded configuration with at least three fold lines to form at least four portions, the first and the second pieces of elongated radio-opaque material positioned inwardly of a pair of outermost ones of the at least four portions of the sponge with respect to a thickness of the sponge in the folded configuration. Folding the piece of gauze into a folded configuration may include folding the piece of gauze to have a first outer panel, a second outer panel, a first inner panel interposed between the first and the second outer panels and a second inner panel interposed between the first and the second outer panels, the first and the second pieces of elongated radio-opaque material carried by at least one of the first or the second inner panels. Folding the piece of gauze into a folded configuration may include folding the piece of gauze about a centerline of the piece of gauze with respect to the length of the piece of gauze, and then folding the piece of gauze about a centerline of the once folded piece of gauze with respect to the length of the once folded piece of gauze in a direct that locates the first and the second pieces of elongated radio-opaque material inwardly of the pair of outermost ones of the at least four portions of the sponge.
The method may further include attaching the transponder to the piece of gauze before folding the piece of gauze into the folded configuration.
The method may further include attaching the first piece of elongated radio-opaque material to the piece of gauze before folding the piece of gauze into the folded configuration.
The method may further include attaching the second piece of elongated radio-opaque material to the piece of gauze before folding the piece of gauze into the folded configuration. The first piece of elongated radio-opaque material may be a first radio-opaque thread and attaching the first piece of elongated radio-opaque material to the piece of gauze before folding the piece of gauze into the folded configuration may include attaching the first radio-opaque thread to the piece of gauze before folding the gauze into the folded configuration.
The second piece of elongated radio-opaque material may be is a second radio-opaque thread, and may further include attaching the second radio-opaque thread to the piece of gauze before folding the gauze into the folded configuration.
The method may further include providing a plurality of additional pieces of gauze in a pre-folded configuration; folding the additional pieces of gauze into respective folded configurations with at least three fold lines to form at least four portions, respective first and second pieces of elongated radio-opaque material positioned inwardly of a pair of outermost ones of the at least four portions of the respective sponges with respect to a thickness of the sponge in the folded configuration; and packaging the sponge and the additional sponges in sets of sponges.
A method of counting sponges in a set of sponges may be summarized as including presenting a set of sponges to a radiological imaging system, the set of sponges comprising a plurality of sponges, each of the sponges in the plurality of sponges comprising a respective piece of gauze folded into at least three panels which overlap with one another, including a first outer panel, a second outer panel and at least a first inner panel located interposed between the first outer panel and the second outer panel, and at least one piece of radio-opaque material carried by the first inner panel; irradiating the set of sponges with electromagnetic radiation (e.g., in the X-ray frequency range); detecting a radiological image that represents the respective at least one piece of radio-opaque material of each of the sponges in the set of sponges; and determining a total number of sponges in the set of sponges based at least in part on the detected radiological image. Irradiating the set of sponges may include irradiating the set of sponges through a respective edge of each of sponges in the set of sponges.
The method may further include providing a notification when the determined number of sponges in the set does not equal a defined number of sponges.
The method may further include applying an indication of certification to the set of sponges in response to a determination that the total number of sponges in the set is equal the defined number of sponges.
The method may further include physically coupling the set of sponges with a band in response to a determination that the total number of sponges in the set is equal the defined number of sponges, the band indicative of certification that the total number of sponges in the set is equal the defined number of sponges.
The method may further include wirelessly interrogating each the transponder of each sponge in the set of sponges; and storing a unique identifier reader from each sponge in the set of sponges in a nontransitory computer-readable memory, indicative of a determination that the total number of sponges in the set is equal the defined number of sponges.
In the drawings, identical reference numbers identify similar elements or acts. The sizes and relative positions of elements in the drawings are not necessarily drawn to scale. For example, the shapes of various elements and angles are not necessarily drawn to scale, and some of these elements may be arbitrarily enlarged and positioned to improve drawing legibility. Further, the particular shapes of the elements as drawn, are not necessarily intended to convey any information regarding the actual shape of the particular elements, and may have been solely selected for ease of recognition in the drawings.
In the following description, certain specific details are set forth in order to provide a thorough understanding of various disclosed embodiments. However, one skilled in the relevant art will recognize that embodiments may be practiced without one or more of these specific details, or with other methods, components, materials, etc. In other instances, well-known structures associated with transmitters, receivers, or transceivers, and types of objects employed in medical procedures, for instance sponges, gauze or other absorbent objects, have not been shown or described in detail to avoid unnecessarily obscuring descriptions of the embodiments.
Unless the context requires otherwise, throughout the specification and claims which follow, the word “comprise” and variations thereof, such as “comprises” and “comprising,” are to be construed in an open, inclusive sense, as “including, but not limited to.”
Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
As used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. It should also be noted that the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The headings and Abstract of the Disclosure provided herein are for convenience only and do not interpret the scope or meaning of the embodiments.
For ease of understanding, a surgical environment will be used as an example environment for detecting objects but such should not be considered limiting.
The piece of gauze 100a has a length 102, that extends between a first end (left-most end) 104 and a second end (right-most end) 106. The piece of gauze 100a has opposed edges 108, 110 across a width 112 of the piece of gauze 100a. The piece of gauze 100a has a first major face 114, and a second major face 116 opposed across a thickness 118 of the piece of gauze 100a from the first major face 114.
As described elsewhere herein, the first wireless transponder 126 may take any of a variety of forms, for example an LC resonant transponder and/or a radio frequency identification (RFID) transponder. The first transponder 126 is positioned to overlie at least a portion of the radio-opaque material 122, 124 when in a folded configuration.
The first wireless transponder 126 may be attached to the piece of gauze 100a via a piece of material or pouch 128, as illustrated in
At this point, the piece of gauze 100a of
The first second radio-opaque material 122, 124 extend across the width 112 of the piece of gauze 100b, and are spaced longitudinally apart from one another along the length 102 of the piece of gauze 100b. In some instances, gauze may be sourced with radio-opaque material woven therein, which typically occurs during creation of the gauze. Alternatively, the manufacture of the sponge may weave the radio-opaque material therein after the gauze has been woven.
As illustrated by arrow 306 in
The piece of gauze 100a, 100b is similar or identical to those of
The piece of gauze 100a, 100b is folded across two fold-lines 404, 406 in a folded configuration. This results in three portions or panels 410, 412, 414 of the piece of gauze overlying one another. Notably, the radio-opaque material 122, 124 is carried on a resulting inner piece or panel 410 of the piece of gauze 100a, 100b with respect to a pair of outer pieces or panels 414, 416 of the piece of gauze 100a, 100b. This again advantageously positions the radio-opaque material 122, 124 and/or transponder 126 (not visible in
The piece of gauze 100a, 100b is similar or identical to those of
The piece of gauze 100a, 100b is folded across two fold-lines 504, 506 in a folded configuration. This results in three portions or panels 510, 512, 514 of the piece of gauze 100a, 100b overlying one another. Notably, the radio-opaque material 122, 124 is carried on a resulting inner piece or panel 510 of the piece of gauze 100a, 100b with respect to a pair of outer pieces or panels 514, 516 of the piece of gauze 100a, 100b. This again advantageously positions the radio-opaque material 122, 124 and/or transponder 126 (not visible in
The piece of gauze 100a, 100b is similar or identical to those of
The piece of gauze is folded across four fold-lines 604, 606, 632, 634 in a folded configuration. This results in five portions or panels 610, 612, 614, 616 (only four called out in
The piece of gauze 100a, 100b is similar or identical to those of
The piece of gauze 100a, 100b is folded across four fold-lines 704, 706, 732, 734 in a folded configuration. This results in five portions or panels 710, 712, 714, 716 (only four called out in
The piece of gauze 100a, 100b is similar or identical to those of
The piece of gauze 100a, 100b is folded across six fold-lines 804, 806, 832, 834, 836, 838 in a folded configuration. This results in seven portions or panels 810, 812, 814, 816 (only four called out in
The piece of gauze 100a, 100b is similar or identical to those of
The piece of gauze 100a, 100b is folded in half, the resulting partially folded piece of gauze 100a, 100b is folded in half again, and then the partially folded piece of gauze 100a, 100b is folded in half a further time. This results in eight portions or panels 910, 912, 914, 916 (only four called out in
The LC resonant transponder 1100 may comprise a core 1104, for example a ferrite core. The core 1104 may, for example take the form of a dumbbell-shaped ferrite rod having broad end portions and a narrow intermediate portion. The broad end portions may provide capacitive functionality. In other implementations, the core 1104 may be shaped as a fusiform-shaped object, with truncated ends.
The LC resonant transponder 1100 may comprise an inductor 1106 formed by a winding which includes a plurality of coils 1108 of an electrically conductive material wrapped around the core 1104. The electrically conductive material may, for example, take the form of electrically conductive wire, for instance copper wire.
The LC resonant transponder 1100 may comprise a capacitor or inherent capacitance 1110, electrically coupled to the inductor 1106. The inductance of the inductor 1106 and the capacitance of the capacitor 1110 are selected to achieved a desired resonant frequency for the LC resonant transponder 1100 (e.g., 145 kHz). For example, the inductive coil and capacitor may together form an inductive/capacitance (L/C) tank circuit. Additional details about types of transponders may be found in U.S. Provisional Patent Application Ser. No. 60/811,376 filed Jun. 6, 2006 and U.S. Provisional Patent Application Ser. No. 60/892,208, filed Feb. 28, 2007, both of which are incorporated herein by reference.
The LC resonant transponder 1100 may be enclosed in an encapsulant or housing 1112 to provide environmental protection to the circuit, and/or to isolate the circuit from bodily tissue. The encapsulant or housing 1112 may advantageously protect the transponder from the ambient environment, for instance from forces, pressure and/or fluids, such as bodily fluids. The encapsulant or housing 1112 preferably comprises a bio-compatible material. The LC resonant transponder 1100 may be relatively small, for example approximately 5-12 millimeters long with a diameter of about 1-4 millimeters.
As previously mentioned, the LC resonant transponder 1100 does not store, encode or otherwise transmit any unique identifying information. As such, the presence transponder 122 may be denominated as a “dumb” transponder. The LC resonant transponder 1100 acts as a simple presence/absence transponder, radiating a return signal in an approximate frequency range when excited by an interrogation signal in or proximate a defined frequency range. The frequency ranges of the interrogation and return signals may be the same or approximately the same (e.g., overlapping). Alternatively, the frequency ranges of the interrogation and return signals may be different from one another (e.g., not overlapping). Lower frequencies may enable superior transmission of signals through bodily tissues or other obstacles including membranes, skin, flesh, etc. Thus, in vivo LC resonant transponder 1100 may be more readily detectable as compared to an in vivo RFID transponder, which typically operate at higher frequencies (e.g., UHF) as compared to an LC resonant transponder 1100.
The pouch 1102 is typically made of material, and forms an interior cavity or interior 1118, into which the LC resonant transponder 1100 and/or an RFID transponder 1200 (
The pouch 1102 is physically coupleable to a piece of gauze 100a, 100b (
In some implementations, the LC resonant transponder 1100 is freely movable within the interior of the pouch 1102. Such may advantageously allow folding, stretching, compression, twisting, or other physical manipulation of the piece of gauze 100a, 100b or sponge without causing damage to the LC resonant transponder 1100. For example, the LC resonant transponder 1100 freely moves within the pouch 1102 to an advantageous position experiencing reduced forces. Likewise, the free-floating LC resonant transponder 1100 does not inhibit folding, stretching, compression, twisting, or other physical manipulation of the piece of gauze 100a, 100b or sponge 300, 400, 500, 600, 700, 800, 900 which may be necessary for the medical procedure.
The RFID transponder 1200 (
The pouch 1102 may be made of any of variety of materials, including textiles, for instance woven or knitted textiles, or membranes, for instance unreinforced or reinforced polymer membranes, or a combination of such. For example, the pouch 1102 may include a first layer 1114 and second layer 1116 that forms the interior 1118 therebetween. The first layer 1114 can be physically coupled to a surface of the piece of gauze 100a, 100b.
The pouch 1102 may be attached to the piece of gauze 100a, 100b via thread for example sewn to the piece of gauze 100a, 100b using one or more stitches 130 (
Additionally or alternatively, the pouch 1102 may optionally include, or may interact with, an adhesive layer 1120 to physically adhere or otherwise attach the pouch 1102 to a piece of gauze 100a, 100b. The adhesive layer 1120 may retain structural and adhesive integrity at least at temperatures equal to 121, 130, 132, 136, and/or 150 degrees Centigrade or higher. For example, the adhesive layer 1120 may not melt or otherwise liquefy and may retain adhesion to the first layer 1114, second layer 1116 and/or the piece of gauze 100a, 100b at temperatures less than or equal to 121, 130, 132, 136, and/or 150 degrees Centigrade or higher. This may permit the pouch 1102 and/or sponge to be sterilized.
Additionally or alternatively, the pouch 1102 may optionally be attached to the piece of gauze 100a, 100b via heat welding, e.g., via a radio frequency (RF) weld.
Additionally or alternatively, the pouch 1102 may optionally be attached to the piece of gauze 100a, 100b via an epoxy, preferably a biocompatible epoxy.
The interior 1118 of the pouch 1102 may be closed or sealed via thread, for example sewn shut using one or more stitches (not shown). Additionally or alternatively, the interior 1118 of the pouch 1102 may be closed or sealed via an adhesive, for instance an adhesive that retains structural integrity at least at temperatures equal to 121, 130, 132, 136, and/or 150 degrees Centigrade or higher. Additionally or alternatively, the interior 1118 of the pouch 1102 may be closed or sealed via may optionally be attached to the piece of gauze 100a, 100b via heat welding, e.g., via a radio frequency (RF) weld.
The first and/or second layers 1114 and 1118 may be fabric laminates or other materials. For example, the first and/or second layers 1114 and 1118 may be one or more of thermoplastic polyurethane (TPU) and nylon fabric; polyvinyl chloride (PVC) impregnated fabric; layer(s) of PVC, TPU, PET, PETG, LDPE, EVA, open celled polyurethanes, or nylon; other fabrics (e.g., cotton, polyester, leather, vinyl, polyethylene, and blended fabrics); other plastics; or combinations thereof. The first and/or second layers 1114 and 1118 are typically relatively thin and may be absorbent or non-absorbent. In some implementations, the first and/or second layers 1114 and 1118 are a material suitable to prevent entry of fluids into the interior cavity of the pouch 1102 (e.g., due to a water-proof or water-resistant coating). Thus, the first and/or second layers 1114 and 1118 may be soft, pliable, and resistant to ripping or tearing.
In one particular example, the first layer 1114 includes a first layer of TPU and a first layer of nylon fabric. The second layer 1116 includes a second layer of TPU and a second layer of nylon fabric. For example, the first and second layers of TPU may respectively be located interior relative to the first and second layers of nylon fabric. In other words, the first and second layers of TPU may contact each other and may form an interior surface of the interior cavity 1118 of the pouch 1102 while the first and second layers of nylon fabric are respectively carried by respective exterior surfaces of the first and second layers of TPU that are opposite to the interior cavity 1118. Such may advantageously allow the first and second layers of TPU to more completely melt together or otherwise physically couple to each other when an RF weld is generated. However, in other implementations, the first and second layers of nylon fabric may be located interior relative to the first and second layers of TPU or may be embedded within the first and second layers of TPU.
Suitable adhesive for the adhesive layer 1120 or to join the first and second layers 1114, 1116 together may include is a hot melt adhesive. For example, the pouch 1102 may be constructed at least in part by causing the temperature of at least a portion the hot melt adhesive to exceed a melting point temperature associated with the hot melt adhesive, thereby causing such portion to at least in part melt. For example, such may be performed using an RF welding machine, planar heat pressing machine, hot-air welding machine, or laminator. Alternatively, the pouch 1102 may be baked (e.g., in a chamber) or exposed to various other techniques for applying heat and/or pressure at desired locations. Generally, the melting point temperature will be at least greater than 130 degrees Centigrade.
The hot melt adhesive is preferably a high temperature hot melt adhesive (i.e., a hot melt adhesive that has a relatively high melting point temperature). For example, the hot melt adhesive may have a melting point temperature of greater than 121, 130, 132, or 136 degrees Centigrade. As another example, the hot melt adhesive layer may have a melting point temperature of about 150 degrees Centigrade or higher. Such may advantageously enhance the ability to sterilize the pouch 1102 or sponge. More particularly, the hot melt adhesive may have a melting point temperature greater than a sterilization temperature associated with one or more sterilization procedures. For example, the hot melt adhesive may have a melting point temperature greater than a steam temperature at which a volume of steam is maintained during one or more steam-based sterilization procedures at some defined pressure. For example, two common steam-based sterilization techniques use a volume of steam respectively maintained at 121 degrees Centigrade (250 degrees Fahrenheit) and 132 degrees Centigrade (270 degrees Fahrenheit). The hot melt adhesive may have a melting point temperature greater than one or both of such temperatures. Further, certain sterilization procedures may be performed with pressure conditions greater than 1 atmosphere. The hot melt adhesive may any of the melting point temperature characteristics described herein at such pressure conditions.
The adhesive is preferably biocompatible, permitting use in vivo.
The adhesive may, for example, take the form of an adhesive web film. The adhesive may, for example, take the form of a thermal lamination film. The adhesive may, for example, take the form of a meltable plastic layer, such as, for example, a thermoplastic layer. The adhesive may be a thermosetting plastic, that has an initial cure temperature at which the thermosetting plastic layer cures. For example, the initial cure temperature may be less than 130 degrees Centigrade. Subsequent to curing, the thermosetting plastic layer may retain structural and adhesive integrity at least at temperatures less than or equal to 121, 130, 132, 136, and/or 150 degrees Centigrade or higher. The adhesive may be a heat-activated adhesive layer. Alternatively or additionally, the adhesive pressure-activated adhesive layer or a pressure-sensitive adhesive layer. Alternatively or additionally, the adhesive may be a water-activated adhesive. The adhesive may, for example, include one or more of a thermoplastic polyurethane, silicone, polyamide, polyethersulfone, polyethylene, polypropylene, and ethylene vinyl acetate.
The RFID transponder 1200 may be received in or form a portion of the pouch 1102 of
The RFID transponder 1200 may include a substrate 1202. For example, the RFID transponder 1200 may include an electrically insulative substrate (e.g., polyester) with one or more electrically conductive traces and/or vias. The substrate 1202 may, for example, take the form of or otherwise comprise a flexible printed circuit board.
The RFID transponder 1200 may include one or more antennas 1204. For example, the RFID transponder 1200 may include a printed or otherwise deposited or etched electrically conductive trace as an antenna 1204 or antenna element. Any of a variety of types of antennas may be employed, for instance a spiral or coil antenna or a T-shaped dipole antenna.
The RFID transponder 1200 may include one or more circuits 1206, carried by the substrate and communicatively coupled to the one or more antennas. Circuits 1206 may take the form of integrated circuits and/or analog or digital circuit elements. Where the RFID transponder 1200 is a passive RFID transponder 1200, the circuit 1206 may include a front end power converter that converts energy from an interrogation signal (e.g., radio frequency, microwave frequency), into DC power to charge a capacitor and power the operation of the RFID transponder 1200. The circuit 1206 may include memory or storage that encodes a unique identifier (i.e., unique over a set of all otherwise identical RFID transponders 1200), which is returned from the RFID transponder 1200 in response to receipt of an interrogation signal, for instance via backscattering.
Even where the identifier is unique, some portion of the identification information or some other identification information may not be unique, for example, a portion representing a manufacturer, a lot, or a type, may be shared between transponders 1200 from the same manufacturer, lot or of the same type. In some implementations, the identification information can be associated with a type of the sponge (e.g., “lap sponge”) or an attribute thereof. For example, the identification information can be linked to the type or attribute using a database, lookup table, or other data structure that cross-references unique identifiers with the type or attribute.
Alternatively, in implementations where the integrated circuit of the RFID transponder 1200 has read and write capability, the identification information can include the desired attribute, pre-stored or written onto the integrated circuit, and directly convey the pre-stored attribute via the first response signal.
Furthermore, in some implementations, the RFID transponder 1200 is a printable and/or ultra-low-cost RFID transponder 1200 that is not necessarily intended to maintain functionality when the sponge used within the surgical environment. In such implementations, the RFID transponder 1200 is interrogated at a conclusion of or during a manufacturing process, for example, to ensure that an appropriate number of sponges are included in a set, packet or package. After such use, the RFID transponder 1200 may not be expected to provide further use and may allowably degrade or otherwise experience damage if the sponge is used within the surgical environment (e.g., in vivo). Such may permit inclusion of low-cost RFID transponders 1200 for use in manufacturing without requiring a hardened or rugged encapsulant or transponder body to protect the transponders 1200 during surgical procedures. Further, the RFID transponder 1200 may be intentionally exposed to Gamma radiation to render the RFID transponder 1200 inoperative prior to delivery or use in a clinical setting.
The imaging system 1600 confirms that a count of the total number of sponges in a set, packet or package of sponges 1602 is correct using imaging technology. The imaging system 1600 may employ a variety of imaging technologies, for example X-ray imaging technology. Thus, the imaging system 1600 may include a source (e.g., X-ray source) 1604 and sensor (e.g., X-ray sensor) 1606 (collectively X-ray machine) to illuminate or irradiate the set, packet or package of sponges 1602, and to identify the radio-opaque material in the sensed image data.
The set, packet or package of sponges 1602 may be carried in a carrier 1608. The carrier 1608 may in turn be carried on a conveyor system (e.g. conveyor belt) 1610 to advance (arrow 1612) the set, packet or package of sponges 1602 into a field of the imaging system 1600. Advantageously, the source transmits electromagnetic radiation (e.g., X-rays) through the sponges endwise (e.g., substantially parallel to the major faces of the sponges), as illustrated by arrow 1614. The sensor 1606 may reside relatively below a portion of the conveyor system 1610, to detect X-rays passing through the sponges 1602. The radio-opaque material on each sponge 1602 will absorb or at least attenuate the X-rays that try to pass through, while the gauze will substantially pass all X-ray radiation. Thus, the radio-opaque material will be clearly discernable and/or detectable in imaging data, for example as spaced black marks or dots. The spacing between adjacent sponges, and hence between sets of black marks or dots will typically be highly repetitive and predictable. Knowledge of the expected spacing can increase the certainty of any evaluation. Evaluation is preferably performed autonomously by a processor-based device (e.g., imaging system, computer), although can alternatively be performed manually. Spacing the radio-opaque material relatively inward in each sponge 1602, advantageously increases the spacing between the radio-opaque material of neighboring or adjacent sponges 1602, enhancing the ability to discern one sponge 1602 from the next, thereby increasing the accuracy of counting. The positioning of the transponders relative to the radio-opaque material may also advantageously eliminate noise or interference in the image data.
The presence of the band 1702 may be indicative that the count of the number of sponges a set, packet or package of sponges 1700 has been checked or verified. The band 1702 may bear one or more indications that the total number of sponges in the set, packet or package of sponges has been checked or verified, and is accurate. For example, the band 1702 may bear a mark or insignia (e.g., trademark) or hologram, collectively 1704, indicative of the accuracy of the count. Additionally or alternatively, the band 1702 may bear a machine-readable symbol (e.g., one-dimensional barcode symbol, two-dimensional matrix code symbol) 1706 indicative of the accuracy of the count. The band may be applied manually or automatically by a machine on confirmation or verification that the count of total sponges in the set, packet or package of sponges 1700 is correct.
The above description of illustrated embodiments, including what is described in the Abstract, is not intended to be exhaustive or to limit the various embodiments to the precise forms disclosed. Although specific embodiments of and examples are described herein for illustrative purposes, various equivalent modifications can be made without departing from the spirit and scope of the disclosure, as will be recognized by those skilled in the relevant art.
The teachings provided herein can be applied to other absorbent materials, other types of transponders, and other interrogation and detection systems. For instance, the transponder device may be used to mark objects anytime detection of the presence of marked objects is desirable in a confined area, not just during surgery. For example, it may be used to make sure marked objects are not left inside a machine (e.g., vehicle, copy machine) after maintenance is performed. In at least some embodiments, the transponder housing may be utilized to mark objects to determine the removal of a marked object from a confined area, such as a cover-all garment from a clean room of a semiconductor fabrication plant. In such an embodiment, an interrogation device, for example, may be placed proximate to a door of the confined area.
In addition, a transponder pouch may be manufactured and distributed for tagging objects without a transponder currently attached or received therein. Advantageously, the pouch can then be used to place a transponder compatible with a particular detection and interrogation system at a subsequent time, including by the end-user.
The various embodiments described above can be combined to provide further embodiments. To the extent that they are not inconsistent with the specific teachings and definitions herein, all of the commonly assigned U.S. patents, U.S. patent application publications, U.S. patent applications referred to in this specification, including but not limited to U.S. Pat. Nos. 8,358,212; 8,710,957; 8,726,911; U.S. Patent Application Publication No. 2010/0108079; U.S. Provisional Patent Application Ser. No. 60/811,376 filed Jun. 6, 2006; U.S. Provisional Patent Application Ser. No. 60/892,208, filed Feb. 28, 2007; U.S. Provisional Patent Application Ser. No. 61/109,142 filed Oct. 28, 2008; U.S. provisional patent application Ser. No. 62/106,052 filed Jan. 21, 2015; and in U.S. provisional patent application Ser. No. 62/138,248 filed Mar. 25, 2015 are incorporated herein by reference, in their entirety. Aspects of the embodiments can be modified, if necessary, to employ systems, circuits and concepts of the various patents, applications and publications to provide yet further embodiments.
These and other changes can be made in light of the above-detailed description. In general, in the following claims, the terms used should not be construed to limit the invention to the specific embodiments disclosed in the specification and the claims, but should be construed to include all possible embodiments along with the full scope of equivalents to which such claims are entitled. Accordingly, the invention is not limited by the disclosure.
This application is a U.S. national stage application filed under 35 U.S.C. § 371 of International Patent Application PCT/US2016/014324, accorded an international filing date of Jan. 21, 2016, which claims the benefit of U.S. Provisional Patent Application Nos. 62/106,052 filed Jan. 21, 2015; 62/138,248 filed Mar. 25, 2015; and 62/164,412 filed May 20, 2015, which applications are incorporated herein by reference in their entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2016/014324 | 1/21/2016 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2016/118749 | 7/28/2016 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2698270 | Mesek | Dec 1954 | A |
2740405 | Riordan | Apr 1956 | A |
3031864 | Freundlich | May 1962 | A |
3123210 | Hermanson et al. | Mar 1964 | A |
3422816 | Robinson et al. | Jan 1969 | A |
3587583 | Greenberg | Jun 1971 | A |
3630202 | Small | Dec 1971 | A |
D240166 | Cartmell et al. | Jun 1976 | S |
3965907 | Hardy | Jun 1976 | A |
4034297 | Giorgi et al. | Jul 1977 | A |
4114601 | Abels | Sep 1978 | A |
4193405 | Abels | Mar 1980 | A |
D272943 | Stone et al. | Mar 1984 | S |
4477256 | Hirsch | Oct 1984 | A |
4540398 | Barson et al. | Sep 1985 | A |
4626251 | Shen | Dec 1986 | A |
4636208 | Rath | Jan 1987 | A |
4639253 | Dyer | Jan 1987 | A |
4645499 | Rupinskas | Feb 1987 | A |
4658818 | Miller, Jr. et al. | Apr 1987 | A |
4681111 | Silvian | Jul 1987 | A |
4704109 | Rupinskas | Nov 1987 | A |
4718897 | Elves | Jan 1988 | A |
4893118 | Lewiner et al. | Jan 1990 | A |
4917694 | Jessup | Apr 1990 | A |
4935019 | Papp, Jr. | Jun 1990 | A |
4938901 | Groitzsch et al. | Jul 1990 | A |
4961495 | Yoshida et al. | Oct 1990 | A |
4992675 | Conner, Jr. et al. | Feb 1991 | A |
5041103 | Rupinskas | Aug 1991 | A |
5045080 | Dyer et al. | Sep 1991 | A |
5049219 | Johns et al. | Sep 1991 | A |
5057095 | Fabian | Oct 1991 | A |
5090410 | Saper et al. | Feb 1992 | A |
5105829 | Fabian et al. | Apr 1992 | A |
5107862 | Fabian et al. | Apr 1992 | A |
5112325 | Zachry | May 1992 | A |
D330872 | Ball | Nov 1992 | S |
5188126 | Fabian et al. | Feb 1993 | A |
5190059 | Fabian et al. | Mar 1993 | A |
5203767 | Cloyd | Apr 1993 | A |
5224593 | Bennett | Jul 1993 | A |
5231273 | Caswell et al. | Jul 1993 | A |
5235326 | Beigel et al. | Aug 1993 | A |
5329944 | Fabian et al. | Jul 1994 | A |
D353343 | Eberhardt | Dec 1994 | S |
D354927 | Andrau | Jan 1995 | S |
D356052 | Andrau | Mar 1995 | S |
D359705 | Ball | Jun 1995 | S |
5446447 | Carney et al. | Aug 1995 | A |
5456718 | Szymaitis | Oct 1995 | A |
5575781 | DeBusk | Nov 1996 | A |
D378614 | Jensen | Mar 1997 | S |
5650596 | Morris et al. | Jul 1997 | A |
5664582 | Szymaitis | Sep 1997 | A |
D385037 | Jensen | Oct 1997 | S |
5725517 | DeBusk | Mar 1998 | A |
5792128 | DeBusk | Aug 1998 | A |
D412135 | Saito | Jul 1999 | S |
5923001 | Morris et al. | Jul 1999 | A |
5931824 | Stewart et al. | Aug 1999 | A |
5963132 | Yoakum | Oct 1999 | A |
5969613 | Yeager et al. | Oct 1999 | A |
D418773 | Saito | Jan 2000 | S |
6026818 | Blair | Feb 2000 | A |
D423673 | Bassøe | Apr 2000 | S |
6093869 | Roe et al. | Jul 2000 | A |
D429337 | Sanfilippo | Aug 2000 | S |
6098800 | Bennish, Jr. et al. | Aug 2000 | A |
6171985 | Joseph et al. | Jan 2001 | B1 |
6172608 | Cole | Jan 2001 | B1 |
6201469 | Balch et al. | Mar 2001 | B1 |
6211666 | Acker | Apr 2001 | B1 |
6232878 | Rubin | May 2001 | B1 |
6276033 | Johnson et al. | Aug 2001 | B1 |
6317027 | Watkins | Nov 2001 | B1 |
6349234 | Pauly et al. | Feb 2002 | B2 |
6353406 | Lanzl et al. | Mar 2002 | B1 |
6354493 | Mon | Mar 2002 | B1 |
6359562 | Rubin | Mar 2002 | B2 |
6366206 | Ishikawa et al. | Apr 2002 | B1 |
D456907 | Sanfilippo | May 2002 | S |
D457634 | Rouns et al. | May 2002 | S |
6384296 | Roe et al. | May 2002 | B1 |
6401722 | Krag | Jun 2002 | B1 |
6441741 | Yoakum | Aug 2002 | B1 |
D471281 | Baura et al. | Mar 2003 | S |
6557752 | Yacoob | May 2003 | B1 |
6566997 | Bradin | May 2003 | B1 |
6588661 | Degrauwe et al. | Jul 2003 | B2 |
6632216 | Houzego et al. | Oct 2003 | B2 |
6641039 | Southard | Nov 2003 | B2 |
6648223 | Boukhny et al. | Nov 2003 | B2 |
6650143 | Peng | Nov 2003 | B1 |
6650240 | Lee et al. | Nov 2003 | B2 |
6667902 | Peng | Dec 2003 | B2 |
6671040 | Fong et al. | Dec 2003 | B2 |
6696954 | Chung | Feb 2004 | B2 |
6700151 | Peng | Mar 2004 | B2 |
6734795 | Price | May 2004 | B2 |
6749554 | Snow et al. | Jun 2004 | B1 |
6753783 | Friedman et al. | Jun 2004 | B2 |
6766960 | Peng | Jul 2004 | B2 |
D495055 | Silber | Aug 2004 | S |
6774800 | Friedman et al. | Aug 2004 | B2 |
6777623 | Ballard | Aug 2004 | B2 |
6777757 | Peng et al. | Aug 2004 | B2 |
6778089 | Yoakum | Aug 2004 | B2 |
6786405 | Wiedenhoefer | Sep 2004 | B2 |
6791891 | Peng et al. | Sep 2004 | B1 |
6798693 | Peng | Sep 2004 | B2 |
6812824 | Goldinger et al. | Nov 2004 | B1 |
6812842 | Dimmer | Nov 2004 | B2 |
6822570 | Dimmer et al. | Nov 2004 | B2 |
6822888 | Peng | Nov 2004 | B2 |
6838990 | Dimmer | Jan 2005 | B2 |
6856540 | Peng et al. | Feb 2005 | B2 |
D502419 | Copen | Mar 2005 | S |
6861639 | Al-Ali | Mar 2005 | B2 |
6861954 | Levin | Mar 2005 | B2 |
6875199 | Altman | Apr 2005 | B2 |
6879300 | Rochelle et al. | Apr 2005 | B2 |
6898116 | Peng | May 2005 | B2 |
6909366 | Marsh et al. | Jun 2005 | B1 |
6940751 | Peng et al. | Sep 2005 | B2 |
D511004 | Masuda | Oct 2005 | S |
6951305 | Overhultz et al. | Oct 2005 | B2 |
6956258 | Peng | Oct 2005 | B2 |
D511384 | Masuda | Nov 2005 | S |
6972986 | Peng et al. | Dec 2005 | B2 |
6977504 | Wright et al. | Dec 2005 | B2 |
6992925 | Peng | Jan 2006 | B2 |
6998541 | Morris et al. | Feb 2006 | B2 |
7001366 | Ballard | Feb 2006 | B2 |
7019650 | Volpi et al. | Mar 2006 | B2 |
7026924 | Degrauwe et al. | Apr 2006 | B2 |
7031209 | Wang et al. | Apr 2006 | B2 |
7037336 | Ward | May 2006 | B2 |
7042722 | Suzuki et al. | May 2006 | B2 |
D526586 | McCaghren et al. | Aug 2006 | S |
7098793 | Chung | Aug 2006 | B2 |
7118029 | Nycz et al. | Oct 2006 | B2 |
7135973 | Kittel et al. | Nov 2006 | B2 |
7135978 | Gisselberg et al. | Nov 2006 | B2 |
7142118 | Hamilton et al. | Nov 2006 | B2 |
7142815 | Desjeux et al. | Nov 2006 | B2 |
D534448 | Shaffer, II et al. | Jan 2007 | S |
7158030 | Chung | Jan 2007 | B2 |
7158754 | Anderson | Jan 2007 | B2 |
7160258 | Imran et al. | Jan 2007 | B2 |
D536673 | Silber | Feb 2007 | S |
7176798 | Dimmer et al. | Feb 2007 | B2 |
7183914 | Norman et al. | Feb 2007 | B2 |
7183927 | Kolton et al. | Feb 2007 | B2 |
7227469 | Varner et al. | Jun 2007 | B2 |
7256695 | Hamel et al. | Aug 2007 | B2 |
7256696 | Levin | Aug 2007 | B2 |
7268684 | Tethrake et al. | Sep 2007 | B2 |
7269047 | Fong et al. | Sep 2007 | B1 |
7299981 | Hickle et al. | Nov 2007 | B2 |
D557423 | Chen | Dec 2007 | S |
D558352 | Sanfilippo | Dec 2007 | S |
7307530 | Fabian et al. | Dec 2007 | B2 |
D558882 | Brady | Jan 2008 | S |
7319396 | Homanfar et al. | Jan 2008 | B2 |
7319397 | Chung et al. | Jan 2008 | B2 |
7325723 | Desjeux | Feb 2008 | B2 |
7333013 | Berger | Feb 2008 | B2 |
7342497 | Chung et al. | Mar 2008 | B2 |
7362228 | Nycz et al. | Apr 2008 | B2 |
D568186 | Blair et al. | May 2008 | S |
7382255 | Chung | Jun 2008 | B2 |
7397364 | Govari | Jul 2008 | B2 |
7399899 | Fabian | Jul 2008 | B2 |
7420468 | Fabian et al. | Sep 2008 | B2 |
7423535 | Chung et al. | Sep 2008 | B2 |
7446646 | Huomo | Nov 2008 | B2 |
7449614 | Ales, III | Nov 2008 | B2 |
7464713 | Fabian et al. | Dec 2008 | B2 |
7465847 | Fabian | Dec 2008 | B2 |
7471541 | Fong et al. | Dec 2008 | B2 |
D584414 | Lash et al. | Jan 2009 | S |
7474222 | Yang et al. | Jan 2009 | B2 |
7492257 | Tethrake et al. | Feb 2009 | B2 |
7492261 | Cambre et al. | Feb 2009 | B2 |
7492263 | Marsilio et al. | Feb 2009 | B2 |
7508308 | Chung | Mar 2009 | B2 |
D590342 | Dávila et al. | Apr 2009 | S |
7513425 | Chung | Apr 2009 | B2 |
7541933 | Volpi et al. | Jun 2009 | B2 |
7557710 | Sanchez et al. | Jul 2009 | B2 |
D598110 | Phillips et al. | Aug 2009 | S |
D598114 | Cryan | Aug 2009 | S |
7596850 | Barth et al. | Oct 2009 | B2 |
7609538 | Lee et al. | Oct 2009 | B1 |
7644016 | Nycz et al. | Jan 2010 | B2 |
7696877 | Barnes et al. | Apr 2010 | B2 |
7703674 | Stewart et al. | Apr 2010 | B2 |
7769422 | DiSilvestro et al. | Aug 2010 | B2 |
7795491 | Stewart et al. | Sep 2010 | B2 |
7816003 | Luchio | Oct 2010 | B1 |
7837694 | Tethrake et al. | Nov 2010 | B2 |
7855656 | Maschke | Dec 2010 | B2 |
7876097 | Greim | Jan 2011 | B2 |
7898420 | Blair et al. | Mar 2011 | B2 |
8072310 | Everhart | Dec 2011 | B1 |
8082192 | Nycz et al. | Dec 2011 | B2 |
8105296 | Morris et al. | Jan 2012 | B2 |
8181860 | Fleck et al. | May 2012 | B2 |
8193938 | Halberthal et al. | Jun 2012 | B2 |
8256674 | Fleck et al. | Sep 2012 | B2 |
8259518 | Peng et al. | Sep 2012 | B2 |
8279068 | Morris et al. | Oct 2012 | B2 |
8358212 | Blair | Jan 2013 | B2 |
8454613 | Tethrake et al. | Jun 2013 | B2 |
8477076 | Nero, Jr. et al. | Jul 2013 | B1 |
8479989 | Fleck et al. | Jul 2013 | B2 |
8576076 | Morris et al. | Nov 2013 | B2 |
8624721 | Barker, Jr. et al. | Jan 2014 | B2 |
8710957 | Blair et al. | Apr 2014 | B2 |
8726911 | Blair | May 2014 | B2 |
8780660 | Peng | Jul 2014 | B2 |
8797820 | Peng et al. | Aug 2014 | B2 |
8872662 | Halberthal et al. | Oct 2014 | B2 |
8878668 | Blair et al. | Nov 2014 | B2 |
8978229 | Halberthal et al. | Mar 2015 | B2 |
8985446 | Fleck et al. | Mar 2015 | B2 |
8994358 | McElhinny et al. | Mar 2015 | B2 |
9041479 | Nero, Jr. et al. | May 2015 | B2 |
9089366 | Garner-Richards et al. | Jul 2015 | B2 |
9119667 | Halberthal et al. | Sep 2015 | B2 |
9168104 | Dein | Oct 2015 | B2 |
9414973 | Fleck et al. | Aug 2016 | B2 |
9507981 | Dor et al. | Nov 2016 | B2 |
9530036 | Fleck et al. | Dec 2016 | B2 |
9672397 | Fleck et al. | Jun 2017 | B2 |
9717565 | Blair | Aug 2017 | B2 |
9730850 | Blair et al. | Aug 2017 | B2 |
9814540 | Blair et al. | Nov 2017 | B2 |
20010000659 | Hayashi et al. | May 2001 | A1 |
20010030610 | Rochelle et al. | Oct 2001 | A1 |
20020011932 | Rodgers et al. | Jan 2002 | A1 |
20020032435 | Levin | Mar 2002 | A1 |
20020070863 | Brooking | Jun 2002 | A1 |
20020143320 | Levin | Oct 2002 | A1 |
20020188259 | Hickle et al. | Dec 2002 | A1 |
20030004411 | Govari et al. | Jan 2003 | A1 |
20030052788 | Kwong-Tai Chung | Mar 2003 | A1 |
20030105394 | Fabian et al. | Jun 2003 | A1 |
20030111592 | Al-Ali | Jun 2003 | A1 |
20040008123 | Carrender et al. | Jan 2004 | A1 |
20040129279 | Fabian et al. | Jul 2004 | A1 |
20040137844 | Desjeux et al. | Jul 2004 | A1 |
20040138554 | Dimmer et al. | Jul 2004 | A1 |
20040250819 | Blair et al. | Dec 2004 | A1 |
20050049564 | Fabian | Mar 2005 | A1 |
20050110640 | Chung | May 2005 | A1 |
20050131397 | Levin | Jun 2005 | A1 |
20050154293 | Gisselberg et al. | Jul 2005 | A1 |
20050203470 | Ballard | Sep 2005 | A1 |
20050212673 | Forster | Sep 2005 | A1 |
20050247794 | Jones et al. | Nov 2005 | A1 |
20050249036 | Davies et al. | Nov 2005 | A1 |
20050267550 | Hess et al. | Dec 2005 | A1 |
20060054107 | Baker | Mar 2006 | A1 |
20060084934 | Frank | Apr 2006 | A1 |
20060106368 | Miller et al. | May 2006 | A1 |
20060187044 | Fabian et al. | Aug 2006 | A1 |
20060202827 | Volpi et al. | Sep 2006 | A1 |
20060232407 | Ballard | Oct 2006 | A1 |
20060235488 | Nycz et al. | Oct 2006 | A1 |
20060241396 | Fabian et al. | Oct 2006 | A1 |
20060241399 | Fabian | Oct 2006 | A1 |
20060244597 | Tethrake et al. | Nov 2006 | A1 |
20060270933 | Benson et al. | Nov 2006 | A1 |
20070000605 | Millette et al. | Jan 2007 | A1 |
20070034670 | Racenet et al. | Feb 2007 | A1 |
20070038233 | Martinez et al. | Feb 2007 | A1 |
20070051473 | Speich | Mar 2007 | A1 |
20070055109 | Bass et al. | Mar 2007 | A1 |
20070069866 | Schuessler et al. | Mar 2007 | A1 |
20070075176 | Andrews et al. | Apr 2007 | A1 |
20070109099 | Raphaeli et al. | May 2007 | A1 |
20070112649 | Schlabach | May 2007 | A1 |
20070125392 | Olson, Jr. et al. | Jun 2007 | A1 |
20070152823 | Hirahara et al. | Jul 2007 | A1 |
20070160494 | Sands | Jul 2007 | A1 |
20070209957 | Glenn et al. | Sep 2007 | A1 |
20070216062 | Frank | Sep 2007 | A1 |
20070216526 | Volpi et al. | Sep 2007 | A1 |
20070219516 | Patel et al. | Sep 2007 | A1 |
20070238982 | Caylor, III | Oct 2007 | A1 |
20070239289 | Cambre et al. | Oct 2007 | A1 |
20070265690 | Lichtenstein et al. | Nov 2007 | A1 |
20070270660 | Caylor, III et al. | Nov 2007 | A1 |
20070281153 | Yamamoto | Dec 2007 | A1 |
20080001760 | Oh et al. | Jan 2008 | A1 |
20080007411 | Levin | Jan 2008 | A1 |
20080018432 | Volpi et al. | Jan 2008 | A1 |
20080020189 | Hofmair et al. | Jan 2008 | A1 |
20080021308 | Dimmer et al. | Jan 2008 | A1 |
20080024277 | Volpi et al. | Jan 2008 | A1 |
20080051746 | Shen-Gunther | Feb 2008 | A1 |
20080086771 | Li et al. | Apr 2008 | A1 |
20080132860 | Smith et al. | Jun 2008 | A1 |
20080231452 | Levin | Sep 2008 | A1 |
20080275327 | Faarbaek et al. | Nov 2008 | A1 |
20080281190 | Petcavich et al. | Nov 2008 | A1 |
20080296373 | Zmood et al. | Dec 2008 | A1 |
20090008449 | Qing et al. | Jan 2009 | A1 |
20090051485 | Corry et al. | Feb 2009 | A1 |
20090267765 | Greene et al. | Oct 2009 | A1 |
20090315681 | Blair | Dec 2009 | A1 |
20090322485 | Barnes et al. | Dec 2009 | A1 |
20100033309 | Blair | Feb 2010 | A1 |
20100108079 | Blair | May 2010 | A1 |
20100109848 | Blair et al. | May 2010 | A1 |
20100179822 | Reppas | Jul 2010 | A1 |
20100259393 | Marur et al. | Oct 2010 | A1 |
20110181394 | Blair | Jul 2011 | A1 |
20120031547 | Halberthal et al. | Feb 2012 | A1 |
20120065566 | Bar-Natan | Mar 2012 | A1 |
20120116499 | Goetzen et al. | May 2012 | A1 |
20130088354 | Thomas | Apr 2013 | A1 |
20130199720 | Halberthal et al. | Aug 2013 | A1 |
20140243770 | Stewart | Aug 2014 | A1 |
20140303580 | Blair | Oct 2014 | A1 |
20150216610 | Augustine | Aug 2015 | A1 |
20150272688 | Blair et al. | Oct 2015 | A1 |
20150317555 | Dor et al. | Nov 2015 | A1 |
20150320506 | Sayles | Nov 2015 | A1 |
20160070942 | Dor et al. | Mar 2016 | A1 |
20160135895 | Faasse et al. | May 2016 | A1 |
20160157957 | Blair | Jun 2016 | A1 |
20160210548 | Blair | Jul 2016 | A1 |
20160212577 | Dor et al. | Jul 2016 | A1 |
20160250000 | Blair | Sep 2016 | A1 |
20170027660 | Blair | Feb 2017 | A1 |
20170296301 | Dor et al. | Oct 2017 | A1 |
20170348172 | Blair et al. | Dec 2017 | A1 |
20180000555 | Blair | Jan 2018 | A1 |
20180000556 | Blair | Jan 2018 | A1 |
Number | Date | Country |
---|---|---|
199852698 | Mar 1993 | AU |
2003249257 | Feb 2004 | AU |
1 171 260 | Jul 1984 | CA |
101460096 | Jun 2009 | CN |
2009151946 | Dec 2009 | CN |
101896131 | Nov 2010 | CN |
1 612 554 | Jan 2006 | EP |
2 087 850 | Aug 2009 | EP |
2009539478 | Nov 2009 | JP |
8602539 | May 1986 | WO |
0239917 | May 2002 | WO |
03073934 | Sep 2003 | WO |
2004008387 | Jan 2004 | WO |
2004054801 | Jul 2004 | WO |
2004086997 | Oct 2004 | WO |
2006060781 | Jun 2006 | WO |
2007120736 | Oct 2007 | WO |
2007146091 | Dec 2007 | WO |
2008008449 | Jan 2008 | WO |
2008024921 | Feb 2008 | WO |
2008106552 | Sep 2008 | WO |
2008112709 | Sep 2008 | WO |
2008133634 | Nov 2008 | WO |
2009154987 | Dec 2009 | WO |
2010134826 | Nov 2010 | WO |
Entry |
---|
Extended European Search Report, dated Jun. 12, 2018, for European Application No. 16740758.4-1113, 11 pages. |
International Search Report for (PCT/US2016/014324) date of completion is Apr. 18, 2016 (5 pages). |
Chinese First Office Action dated Jul. 3, 2019 corresponding to counterpart Patent Application CN 201610035445.2. |
Chinese Search Report dated Jun. 25, 2019 corresponding to counterpart Patent Application CN 201610035445.2. |
Bacheldor, “Surgical Sponges Get Smart,” RFID Journal, Jul. 26, 2006, 2 pages. |
Barnes et al., “Method, Apparatus and Article for Detection of Transponder Tagged Objects, for Example During Surgery,” U.S. Appl. No. 61/056,787, filed May 28, 2008, 60 pages. |
Barnes et al., “Method, Apparatus and Article for Detection of Transponder Tagged Objects, for Example During Surgery,” U.S. Appl. No. 61/091,667, filed Aug. 25, 2008, 76 pages. |
Blair et al., “Apparatus and Method for Detecting Objects Using Tags and Wideband Detection Device,” U.S. Appl. No. 60/811,376, filed Jun. 6, 2006. |
Blair et al., “Method and Apparatus to Detect Transponder Tagged Objects and to Communicate with Medical Telemetry Devices, for Example During Medical Procedures,” U.S. Appl. No. 61/242,699, filed Sep. 15, 2009, 158 pages. |
Blair et al., “Method and Apparatus to Detect Transponder Tagged Objects and to Communicate with Medical Telemetry Devices, for Example During Surgery,” U.S. Appl. No. 61/222,847, filed Jul. 2, 2009, 122 pages. |
Blair et al., “Method and Apparatus to Detect Transponder Tagged Objects, for Example During Medical Procedures,” U.S. Appl. No. 61/242,704, filed Sep. 15, 2009, 127 pages. |
Blair et al., “Method and Apparatus to Detect Transponder Tagged Objects, for Example During Surgery,” U.S. Appl. No. 61/109,104, filed Oct. 28, 2008, 73 pages. |
Blair et al., “Method and Apparatus to Detect Transponder Tagged Objects, for Example During Surgery,” U.S. Appl. No. 61/222,443, filed Jul. 1, 2009, 95 pages. |
Blair et al., “Method, Apparatus and Article for Detection of Transponder Tagged Objects, for Example During Surgery,” U.S. Appl. No. 60/892,208, filed Feb. 28, 2007, 50 pages. |
Blair et al., “Tag and Detection Device,” U.S. Appl. No. 60/458,222, filed Mar. 27, 2003, 23 pages. |
Blair et al., “Transponder Housing and Device to Mark Implements, Such As Surgical Implements, and Method of Using Same,” U.S. Appl. No. 60/894,435, filed Mar. 12, 2007, 30 pages. |
Blair, “Apparatus, Method, and Article for Detection and Identification of Multi-Mode Integral Transponder Tagged Objects,” U.S. Appl. No. 61/056,229, filed May 27, 2008, 38 pages. |
Blair, “Apparatuses to Physically Couple Transponder to Objects, Such As Surgical Objects, and Methods of Using Same,” U.S. Appl. No. 62/121,358, filed Feb. 26, 2015, 88 pages. |
Blair, “Article to Attach a Transponder to a Surgical Sponge,” Design U.S. Appl. No. 29/336,009, filed Apr. 27, 2009, 4 pages. |
Blair, “Attachment Article to Attach a Transponder to a Surgical Sponge,” Design U.S. Appl. No. 29/336,009, filed Apr. 27, 2009, 4 pages. |
Blair, “Attachment Article to Attach a Transponder to a Surgical Sponge,” Design U.S. Appl. No. 29/336,008, filed Apr. 27, 2009, 7 pages. |
Blair, “Detectable Surgical Objects and Methods of Making Same,” U.S. Appl. No. 61/109,142, filed Oct. 28, 2008, 47 pages. |
Blair, “Method and Apparatus to Account for Transponder Tagged Objects Used During Medical Procedures,” U.S. Appl. No. 61/263,726, filed Nov. 23, 2009, 78 pages. |
Blair, “Multi-Modal Transponder and Method and Apparatus to Detect Same,” U.S. Appl. No. 61/102,749, filed Oct. 3, 2008, 48 pages. |
Blair, “Radio Opaque Device with Resonant Nanostructures,” U.S. Appl. No. 61/163,813, filed Mar. 26, 2009, 47 pages. |
Blair, “Transponder Device to Mark Implements, Such as Surgical Implements, and Method of Manufacturing and Using Same,” U.S. Appl. No. 61/086,727, filed Aug. 6, 2008, 30 pages. |
Blair, “Transponder Device to Mark Implements, Such as Surgical Implements, and Method of Manufacturing and Using Same,” U.S. Appl. No. 61/220,452, filed Jun. 25, 2009, 46 pages. |
Blair, “Transponder Device to Mark Implements, Such as Surgical Implements, and Method of Manufacturing and Using Same,” U.S. Appl. No. 61/224,323, filed Jul. 9, 2009, 57 pages. |
Blair, “Transponder Housing,” Design U.S. Appl. No. 29/322,539, filed Aug. 6, 2008, 6 pages. |
Clearcount Medical Solutions, “The SmartSponge System,” Downloaded Oct. 20, 2009. |
Extended European Search Report, dated Jul. 30, 2015, for European Application No. 14176398.7, 7 pages. |
Haldor Advanced Technologies, “Haldor Advanced Technologies Releases a Breakthrough New Sponge Management Solution: Modular, Mobile, Wireless, and Tailored per Use-case and Requirements,” Sep. 8, 2015, retrieved from http://ww1.prweb.com/prfiles/2015/09/06/12938762/ORLocate%205Sponge%20Solution-September%202015.pdf, 2 pages. |
International Search Report, dated Dec. 23, 2014, for PCT/US2014/045942, 3 pages. |
International Search Report, dated May 13, 2016, for International Application No. PCT/US2016/014335, 3 pages. |
Macario, et al., “Initial Clinical Evaluation of a Handheld Device for Detecting Retained Surgical Gauze Sponges Using Radiofrequency Identification Technology,” Arch. Surg.,vol. 14, Jul. 2005, pp. 659-662. |
Technologies Solutions Group, “ORtrack,” 2013, 2 pages. |
Technologies Solutions Group, “Sponge-Track,” 2013, 2 pages. |
Written Opinion, dated Dec. 23, 2014, for PCT/US2014/045942, 7 pages. |
Written Opinion, dated May 2, 2016, for International Application No. PCT/US2016/014324, 13 pages. |
Australian Examination Report No. 1 dated Aug. 7, 2019 corresponding to counterpart Patent Application AU 2016200113. |
Chinese Office Action for application No. 201680006406.8 dated Apr. 16, 2020 with English translation. |
Number | Date | Country | |
---|---|---|---|
20180333309 A1 | Nov 2018 | US |
Number | Date | Country | |
---|---|---|---|
62106052 | Jan 2015 | US | |
62138248 | Mar 2015 | US | |
62164412 | May 2015 | US |